H.R. 4880 · 117th Congress · House

Veterans’ Prostate Cancer Treatment and Research Act

Active· Referred to the Subcommittee on Health.
Introduced
Jul 30, 21
Passed House
Pending
Passed Senate
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

Veterans' Prostate Cancer Treatment and Research Act

This bill requires the Department of Veterans Affairs (VA) to establish in its National Surgery Office an interdisciplinary clinical pathway for all stages of prostate cancer. Clinical pathways are health care management tools designed around research and evidence-based practices that provide direction for the care and treatment of a specific condition. The clinical pathway must include specified elements, such as a diagnosis pathway and a treatment pathway.

The VA must consult with and incorporate feedback from (1) veterans who have received prostate cancer care at its medical facilities, and (2) experts in multidisciplinary cancer care and clinical research.

Additionally, the VA must publish the clinical pathway on a public VA website and annually update the pathway as needed based on medical literature and evidence-based guidelines.

The bill also requires the VA to submit a plan to establish a prostate cancer program using the comprehensive prostate cancer clinical pathway.

Action Timeline

4
  1. SEP 09, 2021Committee

    Referred to the Subcommittee on Health.

  2. JUL 30, 2021IntroReferral

    Introduced in House

  3. JUL 30, 2021IntroReferral

    Introduced in House

  4. JUL 30, 2021IntroReferral

    Referred to the House Committee on Veterans' Affairs.

Committees

2

Health Subcommittee

hsvr03

Referred: Sep 9, 2021

Active

Veterans' Affairs Committee

hsvr00

Referred: Jul 30, 2021

Active